KORELASI DURASI PENGGUNAAN KONTRASEPSI ORAL DAN STADIUM KANKER SERVIKS DI RSUD ARIFIN ACHMAD PROVINSI RIAU

  • Feriandri Utomo Universitas Abdurrab
  • Ahmad Afandi Universitas Abdurrab
  • Syamsul Bahri Rivai Universitas Abdurrab

Abstract

Insidensi kanker serviks terus meningkat, termasuk di RSUD Arifin Achmad Provinsi Riau, di mana terjadi hampir 8 kali peningkatan insidensi kanker serviks pada tahun 2017 dibandingkan pada tahun 2016. Penggunaan kontrasepsi oral yang menjadi salah satu faktor risiko kanker serviks, juga mengalami peningkatan drastis di Provinsi Riau. Durasi penggunaan kontrasepsi oral terbukti berhubungan signifikan terhadap peningkatan risiko Cervical Intraepithelial Neoplasia grade 3 (CIN3). Penelitian ini bertujuan untuk menganalisis hubungan antara durasi penggunaan kontrasepsi oral dengan stadium kanker serviks. Penelitian ini merupakan penelitian analitik observasional, dengan rancangan cross sectional. Pengambilan sampel dilakukan dengan teknik total sampling pada data rekam medis pasien selama tahun 2017 di RSUD Arifin Achmad Provinsi Riau dan diuji secara statistik menggunakan uji korelasi Spearman Rank. Penelitian ini menemukan terdapat korelasi kuat yang signifikan antara durasi penggunaan kontrasepsi oral dengan stadium kanker serviks (p-value < 0,05 dan r = 0,74). Selain itu, durasi penggunaan kontrasepsi oral berpengaruh terhadap peningkatan stadium kanker serviks sebesar 54,7% (r2 =  0,547). Dari penelitian ini dapat disimpulkan bahwa durasi penggunaan konstrasepsi oral sangat berhubungan dengan peningkatan stadium kanker serviks.

Keywords: Kanker, Kontrasepsi, Serviks, Stadium

References

Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., et al. ‘Cancer incidence and mortality - Major patterns in GLOBOCAN 2012, worldwide and Georgia’, Bulletin of the Georgian National Academy of Sciences. 2015; 9(1), pp. 168–173. doi: 10.1002/ijc.29210.

Domingo E.J., Noviani R., Noor M.R.Md., Ngelangel C.A., Limpaphayom K.K., Thuan T.V., Louie K.S., et al. ‘Epidemiology and Prevention of Cervical Cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam’, Vaccine. 2008; 26(SUPPL. 12). doi: 10.1016/j.vaccine.2008.05.039.

Momenimovahed, Z. and Salehiniya, H. Incidence, mortality and risk factors of cervical cancer in the world, Biomedical Research and Therapy. 2017; 4(12), p. 1795. doi: 10.15419/bmrat.v4i12.386.

Wulandari, V. ‘Hubungan Faktor Risiko Penggunaan Kontrasepsi Oral dan Aktivitas Seksual Dengan Kejadian Kanker Serviks’, Jurnal Berkala Epidemiologi. 2016; 4(3), pp. 408–419. doi: 10.20473/jbe.v4i3.

Rouora E., Travier N., Waterboer T., Sanjoese S.D., Bosch F.X., Pawlita M., Pala V., et al. ‘The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer’, Indian Journal of Animal Sciences. 2016; 80(4 SUPPL. 1), pp. 85–97. doi: 10.1371/journal.pone.0147029.

BKKBN. PESERTA KB AKTIF MENURUT METODE KONTRASEPSI BULAN : Agustus 2018; 2018a. Available from: http://aplikasi.bkkbn.go.id/sr/DALLAP/Laporan2013/Bulanan/Dalap2013Tabel15.aspx (Diakses 18 September 2018).

Kumar, V., K.Abbas, A. and C.Aster, J. BUKU AJAR PATOLOGI Robbins. 9th edn. Edited by S. Tharmapalan. Singapore: Elsevier (Singapore); 2015.

Volpato L.K., Siqueira I.R., Nunes R.D., Piovezan A.P. ‘Association between hormonal contraception and injuries induced by human papillomavirus in the Uterine Cervix’, Revista Brasileira de Ginecologia e Obstetricia. 2018; 40(4), pp. 196–202. doi: 10.1055/s-0038-1642603.

Vaisy, A., Lotfinejad, S. and Zhian, F. ‘Risk of Cancer with Combined Oral Contraceptive Use among Iranian Women’, 15, pp. 5517–5522; 2014.

Zidi S., Sahli M., Mezlini A., Loueslati B.Y. ‘Association of Combined Tobacco Smoking, Hormonal Contraceptive use and Status Matrimonial with Cervical Cancer Evolution in Tunisian Women’. Pathology & Oncology Research; 2018.

Oh, H. Y., Kim M. K., Seo, S. S., Lee J. ‘Association of Combined Tobacco Smoking and Oral Contraceptive Use With Cervical Intraepithelial Neoplasia 2 or 3 in Korean Women’. 2016; 26(1), pp. 22–29. doi: 10.2188/jea.JE20150047.

Berraho, M., Riffi A. A., El-Mzibir M., Bezad R., Benjaafar N., Benideer A., et al ‘HPV and cofactors for invasive cervical cancer in Morocco : a multicentre case- control study’. BMC Cancer. 2017; pp. 1–9. doi: 10.1186/s12885-017-3425-z.

Luhn, P., Walker J., Schiffman M., Zuna R. E., Dunn S. T., Gold M. A., Smith K. et al. ‘The role of co-factors in the progression from human papillomavirus infection to cervical cancer’, Gynecologic Oncology. Elsevier B.V. 2013; 128(2), pp. 265–270. doi: 10.1016/j.ygyno.2012.11.003.

Xu H., Egger S., Valentzis L. S., O'Connel D. L., Banks E., Brown J. D., Canfell K. ‘Hormonal contraceptive use and smoking as risk factors for high-grade cervical intraepithelial neoplasia in unvaccinated women aged 30 – 44 years : A case-control study in New South Wales , Australia’, Cancer Epidemiology. Elsevier. 2018; 55(March), pp. 162–169. doi: 10.1016/j.canep.2018.05.013.

Khatun, S. F., Khatun S., Hossain A. K. M. F., Nahar K. ‘Prolonged use of oral contraceptive pill , a co-factor for the development of cervical cancer’, A Journal of Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. 2018; doi: 10.3329/bsmmuj.v11i3.37279.

Samir, R., Tot T., Asplund A., Pekar G., Hellberg D. ‘Increased Serum Progesterone and Estradiol Correlate to Increased COX-2 Tissue Expression in Cervical Intraepithelial Neoplasia’. 2010; 1222, pp. 1217–1222.

Published
2020-01-21
Section
Articles
PDF
Abstract views: 51
downloads: 36